ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1016 participants.
Also called NCT06608823
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,016 participants
- Sponsor
- Registry
-
NCT06608823
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06608823. Randomized; no masking; primary purpose treatment. Start 2025-06-18 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- Acronym
- ARTIST
- Condition
- Aortic Regurgitation
- Condition
- Aortic Valve Insufficiency
- Condition
- Aortic Insufficiency
- Intervention (Device)
- Transcatheter Aortic Valve Replacement (TAVR (transcatheter aortic valve replacement)) using Trilogy THV System
- Intervention (Device)
- SAVR
- Lead sponsor
- JenaValve Technology, Inc.
Record details
- Record id
cardio:ct-nct06608823- Content hash
05d8fd89b9eb3613b46b7d00f2d5d173b2e1365b5d9f1c1a48ee98e389268a9e